- Home
- TOPP vs BOLD Comparison
TOPP vs BOLD Comparison
Compare TOPP & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- BOLD
- Stock Information
- Founded
- TOPP 2014
- BOLD 2018
- Country
- TOPP United States
- BOLD United States
- Employees
- TOPP N/A
- BOLD N/A
- Industry
- TOPP
- BOLD
- Sector
- TOPP
- BOLD
- Exchange
- TOPP NYSE
- BOLD Nasdaq
- Market Cap
- TOPP 26.6M
- BOLD 30.3M
- IPO Year
- TOPP 2025
- BOLD 2024
- Fundamental
- Price
- TOPP $1.79
- BOLD $1.18
- Analyst Decision
- TOPP
- BOLD Buy
- Analyst Count
- TOPP 0
- BOLD 3
- Target Price
- TOPP N/A
- BOLD $4.00
- AVG Volume (30 Days)
- TOPP 31.1K
- BOLD 82.5K
- Earning Date
- TOPP 05-15-2025
- BOLD 05-09-2025
- Dividend Yield
- TOPP N/A
- BOLD N/A
- EPS Growth
- TOPP N/A
- BOLD N/A
- EPS
- TOPP N/A
- BOLD N/A
- Revenue
- TOPP $16,117,227.00
- BOLD N/A
- Revenue This Year
- TOPP N/A
- BOLD N/A
- Revenue Next Year
- TOPP N/A
- BOLD N/A
- P/E Ratio
- TOPP N/A
- BOLD N/A
- Revenue Growth
- TOPP 0.44
- BOLD N/A
- 52 Week Low
- TOPP $0.97
- BOLD $1.06
- 52 Week High
- TOPP $4.50
- BOLD $10.13
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- BOLD N/A
- Support Level
- TOPP N/A
- BOLD N/A
- Resistance Level
- TOPP N/A
- BOLD N/A
- Average True Range (ATR)
- TOPP 0.00
- BOLD 0.00
- MACD
- TOPP 0.00
- BOLD 0.00
- Stochastic Oscillator
- TOPP 0.00
- BOLD 0.00
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.